[1]
Almeida, A., Pierdomenico, F., Guerrero, B.P., Saraiva, F., Montalvão, A., Coutinho, J., Mariz, M., Melo, T., Santos, M.J., Pereira, A. and Cerveira, N. 2019. Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice. Acta Médica Portuguesa. 32, 7-8 (Aug. 2019), 550–557. DOI:https://doi.org/10.20344/amp.11823.